Abstract
The term sphingolipid was coined by J.L.W. Thudichum before the turn of the nineteenth century, referring to the enigmatic (related to the Sphinx myth) nature of this class of molecules. One hundred thirty years later, the enigma is not yet completely solved. Nevertheless, much progress has been made, shedding light on the numerous roles these lipids play in eukaryotes. How sphingolipids are synthesized, transformed and degraded in mammalian cells, and how some of them transduce signals and regulate biological functions is reviewed in this chapter. Special attention is given to those sphingolipid species which regulate key aspects of the development of malignancies in humans, and therefore represent potential targets for therapy.
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-3-319-20750-6_21
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Cer:
-
Ceramide
- Cer1P:
-
Ceramide 1-phosphate
- DAG:
-
Diacylglycerol
- ER:
-
Endoplasmic reticulum
- GalCer:
-
Galactosylceramide
- GlcCer:
-
Glucosylceramide
- GSL:
-
Glycosphingolipid
- S1P:
-
Sphingosine 1-phosphate
- SL:
-
Sphingolipid
- SM:
-
Sphingomyelin
- SPC:
-
Sphingosylphosphocholine
References
Merrill AH Jr, Stokes TH, Momin A et al (2009) Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J Lipid Res 50(Suppl):S97–102
Sabourdy F, Kedjouar B, Sorli SC et al (2008) Functions of sphingolipid metabolism in mammals—lessons from genetic defects. Biochim Biophys Acta 1781:145–183
Jennemann R, Grone HJ (2013) Cell-specific in vivo functions of glycosphingolipids: lessons from genetic deletions of enzymes involved in glycosphingolipid synthesis. Prog Lipid Res 52:231–248
Albinet V, Bats ML, Bedia C et al (2013) Genetic disorders of simple sphingolipid metabolism. Handb Exp Pharmacol 7:127–152. doi:10.1007/978-3-7091-1368-4
Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139–150
Pyne NJ, Pyne S (2010) Sphingosine 1-phosphate and cancer. Nat Rev Cancer 10:489–503
Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22:50–60
Morad SA, Cabot MC (2013) Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 13:51–65
Kunkel GT, Maceyka M, Milstien S, Spiegel S (2013) Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov 12:688–702
Grosch S, Schiffmann S, Geisslinger G (2012) Chain length-specific properties of ceramides. Prog Lipid Res 51:50–62
Penno A, Reilly MM, Houlden H et al (2010) Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem 285:11178–11187
Bertea M, Rutti MF, Othman A et al (2010) Deoxysphingoid bases as plasma markers in diabetes mellitus. Lipids Health Dis 9:84
Funato K, Riezman H (2001) Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast. J Cell Biol 155:949–959
Hanada K, Kumagai K, Yasuda S et al (2003) Molecular machinery for non-vesicular trafficking of ceramide. Nature 426:803–809
Halter D, Neumann S, van Dijk SM et al (2007) Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis. J Cell Biol 179:101–115
Simanshu DK, Kamlekar RK, Wijesinghe DS et al (2013) Non-vesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids. Nature 500:463–467
Swanton C, Marani M, Pardo O et al (2007) Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell 11:498–512
Wennekes T, van den Berg RJ, Boot RG, van der Marel GA, Overkleeft HS, Aerts JM (2009) Glycosphingolipids—nature, function, and pharmacological modulation. Angew Chem Int Ed Engl 48:8848–8869
D’Angelo G, Capasso S, Sticco L, Russo D (2013) Glycosphingolipids: synthesis and functions. FEBS J 280:6338–6353
Kolter T, Sandhoff K (2010) Lysosomal degradation of membrane lipids. FEBS Lett 584:1700–1712
Kihara A (2014) Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids. Biochim Biophys Acta 1841:766–772
Tani M, Ito M, Igarashi Y (2007) Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell Signal 19:229–237
Jenkins RW, Canals D, Hannun YA (2009) Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 21:836–846
Duan RD (2011) Physiological functions and clinical implications of sphingolipids in the gut. J Dig Dis 12:60–70
Birbes H, El Bawab S, Obeid LM, Hannun YA (2002) Mitochondria and ceramide: intertwined roles in regulation of apoptosis. Adv Enzyme Regul 42:113–129
Morales A, Colell A, Mari M, Garcia-Ruiz C, Fernandez-Checa JC (2004) Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J 20:579–588
Lucki NC, Sewer MB (2012) Nuclear sphingolipid metabolism. Annu Rev Physiol 74:131–151
Mao C, Obeid LM (2008) Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim Biophys Acta 1781:424–434
Hannun YA, Bell RM (1987) Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235:670–674
Breslow DK, Weissman JS (2010) Membranes in balance: mechanisms of sphingolipid homeostasis. Mol Cell 40:267–279
Miyatake T, Suzuki K (1972) Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase. Biochem Biophys Res Commun 48:539–543
Vanier MT, Svennerholm L (1975) Chemical pathology of Krabbe’s disease. III. Ceramide-hexosides and gangliosides of brain. Acta Paediatr Scand 64:641–648
Im DS, Heise CE, Nguyen T, O’Dowd BF, Lynch KR (2001) Identification of a molecular target of psychosine and its role in globoid cell formation. J Cell Biol 153:429–434
Radu CG, Cheng D, Nijagal A et al (2006) Normal immune development and glucocorticoid-induced thymocyte apoptosis in mice deficient for the T-cell death-associated gene 8 receptor. Mol Cell Biol 26:668–677
Wang JQ, Kon J, Mogi C et al (2004) TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J Biol Chem 279:45626–45633
Okazaki T, Bell RM, Hannun YA (1989) Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem 264:19076–19080
Kolesnick RN (1989) Sphingomyelinase action inhibits phorbol ester-induced differentiation of human promyelocytic leukemic (HL-60) cells. J Biol Chem 264:7617–7623
Hannun YA (1994) The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125–3128
Levade T, Jaffrezou JP (1999) Signalling sphingomyelinases: which, where, how and why? Biochim Biophys Acta 1438:1–17
Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405–414
Park JW, Park WJ, Futerman AH (2014) Ceramide synthases as potential targets for therapeutic intervention in human diseases. Biochim Biophys Acta 1841:671–681
Watanabe M, Kitano T, Kondo T et al (2004) Increase of nuclear ceramide through caspase-3-dependent regulation of the “sphingomyelin cycle” in Fas-induced apoptosis. Cancer Res 64:1000–1007
Lafont E, Milhas D, Carpentier S et al (2010) Caspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death. Cell Death Differ 17:642–654
Bedia C, Casas J, Andrieu-Abadie N, Fabrias G, Levade T (2011) Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine. J Biol Chem 286:28200–28209
Valaperta R, Chigorno V, Basso L et al (2006) Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts. FASEB J 20:1227–1229
Sorli SC, Colie S, Albinet V et al (2013) The nonlysosomal beta-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells. FASEB J 27:489–498
Ghosh TK, Bian J, Gill DL (1990) Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science 248:1653–1656
Zhang H, Desai NN, Olivera A, Seki T, Brooker G, Spiegel S (1991) Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 114:155–167
Auge N, Nikolova-Karakashian M, Carpentier S et al (1999) Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J Biol Chem 274:21533–21538
Kumar A, Byun HS, Bittman R, Saba JD (2011) The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner. Cell Signal 23:1144–1152
Chipuk JE, McStay GP, Bharti A et al (2012) Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148:988–1000
Cuvillier O, Pirianov G, Kleuser B et al (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800–803
Mesicek J, Lee H, Feldman T et al (2010) Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal 22:1300–1307
Olivera A, Spiegel S (1993) Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365:557–560
Strub GM, Maceyka M, Hait NC, Milstien S, Spiegel S (2010) Extracellular and intracellular actions of sphingosine-1-phosphate. Adv Exp Med Biol 688:141–155
Spiegel S, Milstien S (2011) The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 11:403–415
Lee MJ, Van Brocklyn JR, Thangada S et al (1998) Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279:1552–1555
Blaho VA, Hla T (2014) An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res 55:1596–1608
Alvarez SE, Harikumar KB, Hait NC et al (2010) Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465:1084–1088
Hait NC, Allegood J, Maceyka M et al (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325:1254–1257
Strub GM, Paillard M, Liang J et al (2011) Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J 25:600–612
Laviad EL, Albee L, Pankova-Kholmyansky I et al (2008) Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem 283:5677–5684
Hannun YA, Loomis CR, Merrill AH Jr, Bell RM (1986) Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 261:12604–12609
Merrill AH Jr, Sereni AM, Stevens VL, Hannun YA, Bell RM, Kinkade JM Jr (1986) Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine and other long-chain bases. J Biol Chem 261:12610–12615
Wilson E, Olcott MC, Bell RM, Merrill AH Jr, Lambeth JD (1986) Inhibition of the oxidative burst in human neutrophils by sphingoid long-chain bases. Role of protein kinase C in activation of the burst. J Biol Chem 261:12616–12623
Cuvillier O (2002) Sphingosine in apoptosis signaling. Biochim Biophys Acta 1585:153–162
Symolon H, Schmelz EM, Dillehay DL, Merrill AH Jr (2004) Dietary soy sphingolipids suppress tumorigenesis and gene expression in 1,2-dimethylhydrazine-treated CF1 mice and ApcMin/+ mice. J Nutr 134:1157–1161
Fyrst H, Oskouian B, Bandhuvula P et al (2009) Natural sphingadienes inhibit Akt-dependent signaling and prevent intestinal tumorigenesis. Cancer Res 69:9457–9464
Kumar A, Pandurangan AK, Lu F et al (2012) Chemopreventive sphingadienes downregulate Wnt signaling via a PP2A/Akt/GSK3beta pathway in colon cancer. Carcinogenesis 33:1726–1735
Degagne E, Pandurangan A, Bandhuvula P et al (2014) Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. J Clin Invest 124:5368–5384
Snook CF, Jones JA, Hannun YA (2006) Sphingolipid-binding proteins. Biochim Biophys Acta 1761:927–946
Saddoughi SA, Ogretmen B (2013) Diverse functions of ceramide in cancer cell death and proliferation. Adv Cancer Res 117:37–58
Young MM, Kester M, Wang HG (2013) Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J Lipid Res 54:5–19
Garcia-Barros M, Coant N, Truman JP, Snider AJ, Hannun YA (2014) Sphingolipids in colon cancer. Biochim Biophys Acta 1841:773–782
Huwiler A, Fabbro D, Pfeilschifter J (1998) Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells. Biochemistry 37:14556–14562
Wang G, Silva J, Krishnamurthy K, Tran E, Condie BG, Bieberich E (2005) Direct binding to ceramide activates protein kinase Czeta before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells. J Biol Chem 280:26415–26424
Yin X, Zafrullah M, Lee H, Haimovitz-Friedman A, Fuks Z, Kolesnick R (2009) A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation. Cell Physiol Biochem 24:219–230
Mukhopadhyay A, Saddoughi SA, Song P et al (2009) Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling. FASEB J 23:751–763
Edmond V, Dufour F, Poiroux G et al (2015) Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility. Oncogene 34:996–1005. doi:10.1038/onc.2014.55
van Blitterswijk WJ, van der Luit AH, Veldman RJ, Verheij M, Borst J (2003) Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J 369:199–211
Goni FM, Alonso A (2006) Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim Biophys Acta 1758:1902–1921
Zhang Y, Li X, Becker KA, Gulbins E (2009) Ceramide-enriched membrane domains—structure and function. Biochim Biophys Acta 1788:178–183
Hakomori S (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci U S A 99:10231–10233
Fredman P, Hedberg K, Brezicka T (2003) Gangliosides as therapeutic targets for cancer. BioDrugs 17:155–167
Furukawa K, Hamamura K, Aixinjueluo W, Furukawa K (2006) Biosignals modulated by tumor-associated carbohydrate antigens: novel targets for cancer therapy. Ann N Y Acad Sci 1086:185–198
Handa K, Hakomori SI (2012) Carbohydrate to carbohydrate interaction in development process and cancer progression. Glycoconj J 29:627–637
Giussani P, Tringali C, Riboni L, Viani P, Venerando B (2014) Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance. Int J Mol Sci 15:4356–4392
Hossain DM, Mohanty S, Ray P, Das T, Sa G (2012) Tumor gangliosides and T cells: a deadly encounter. Front Biosci (Schol Ed) 4:502–519
Liu Y, Wondimu A, Yan S, Bobb D, Ladisch S (2013) Tumor gangliosides accelerate murine tumor angiogenesis. Angiogenesis 17:563–571. doi:10.1007/s10456-013-9403-4
Ward PS, Patel J, Wise DR et al (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17:225–234
Avery K, Avery S, Shepherd J, Heath PR, Moore H (2008) Sphingosine-1-phosphate mediates transcriptional regulation of key targets associated with survival, proliferation, and pluripotency in human embryonic stem cells. Stem Cells Dev 17:1195–1205
Ader I, Malavaud B, Cuvillier O (2009) When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. Cancer Res 69:3723–3726
Xia P, Gamble JR, Wang L et al (2000) An oncogenic role of sphingosine kinase. Curr Biol 10:1527–1530
Trajkovic K, Hsu C, Chiantia S et al (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244–1247
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Moon SK, Kim HM, Lee YC, Kim CH (2004) Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. J Biol Chem 279:33063–33070
Wang H, Isaji T, Satoh M, Li D, Arai Y, Gu J (2013) Antitumor effects of exogenous ganglioside GM3 on bladder cancer in an orthotopic cancer model. Urology 81(210):e211–215
Shirahama T, Sweeney EA, Sakakura C et al (1997) In vitro and in vivo induction of apoptosis by sphingosine and N, N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells. Clin Cancer Res 3:257–264
Desai NN, Carlson RO, Mattie ME et al (1993) Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. J Cell Biol 121:1385–1395
Endo K, Igarashi Y, Nisar M, Zhou QH, Hakomori S (1991) Cell membrane signaling as target in cancer therapy: inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Res 51:1613–1618
Webb TJ, Li X, Giuntoli RL 2nd et al (2012) Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res 72:3744–3752
Zhou D (2006) The immunological function of iGb3. Curr Protein Pept Sci 7:325–333
Shimizu K, Kurosawa Y, Taniguchi M, Steinman RM, Fujii S (2007) Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J Exp Med 204:2641–2653
Maru M, Haraguchi M, Higashi H et al (1993) Anti-tumor activity of ceramides and glycosphingolipids in a murine tumor system. Int J Cancer 53:645–650
van Vlerken LE, Duan Z, Little SR, Seiden MV, Amiji MM (2010) Augmentation of therapeutic efficacy in drug-resistant tumor models using ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systems. AAPS J 12:171–180
Parameswaran R, Lim M, Arutyunyan A et al (2013) O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia. J Exp Med 210:805–819
Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC (1996) Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 271:19530–19536
Ponnusamy S, Meyers-Needham M, Senkal CE et al (2010) Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol 6:1603–1624
Bocci G, Fioravanti A, Orlandi P et al (2012) Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1. Neoplasia 14:833–845
Seyfried TN, Mukherjee P (2010) Ganglioside GM3 is antiangiogenic in malignant brain cancer. J Oncol 2010:961243
Visentin B, Vekich JA, Sibbald BJ et al (2006) Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9:225–238
Cazet A, Groux-Degroote S, Teylaert B et al (2009) GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells. Biol Chem 390:601–609
Yan Q, Bach DQ, Gatla N et al (2013) Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma. Mol Cancer Res 11:665–675
Ratajczak MZ, Suszynska M, Borkowska S, Ratajczak J, Schneider G (2014) The role of sphingosine-1 phosphate and ceramide-1 phosphate in trafficking of normal stem cells and cancer cells. Expert Opin Ther Targets 18:95–107
Takenaga M, Igarashi R, Matsumoto K et al (1999) Lipid microsphere preparation of a lipophilic ceramide derivative suppresses colony formation in a murine experimental pulmonary metastasis model. J Drug Target 7:187–195
Beil M, Micoulet A, von Wichert G et al (2003) Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nat Cell Biol 5:803–811
Sadahira Y, Ruan F, Hakomori S, Igarashi Y (1992) Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Proc Natl Acad Sci U S A 89:9686–9690
Birks SM, Danquah JO, King L, Vlasak R, Gorecki DC, Pilkington GJ (2011) Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma. Neuro Oncol 13:950–960
Bennaceur K, Popa I, Chapman JA et al (2009) Different mechanisms are involved in apoptosis induced by melanoma gangliosides on human monocyte-derived dendritic cells. Glycobiology 19:576–582
Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science 259:1769–1771
Kota V, Dhople VM, Fullbright G et al (2013) 2′-Hydroxy C16-ceramide induces apoptosis-associated proteomic changes in C6 glioma cells. J Proteome Res 12:4366–4375
Sakakura C, Sweeney EA, Shirahama T, Hakomori S, Igarashi Y (1996) Suppression of bcl-2 gene expression by sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-induced terminal differentiation. FEBS Lett 379:177–180
Bleicher RJ, Cabot MC (2002) Glucosylceramide synthase and apoptosis. Biochim Biophys Acta 1585:172–178
Bektas M, Jolly PS, Muller C, Eberle J, Spiegel S, Geilen CC (2005) Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 24:178–187
Sauer B, Gonska H, Manggau M et al (2005) Sphingosine 1-phosphate is involved in cytoprotective actions of calcitriol in human fibroblasts and enhances the intracellular Bcl-2/Bax rheostat. Pharmazie 60:298–304
Li QF, Wu CT, Guo Q, Wang H, Wang LS (2008) Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis. Biochem Biophys Res Commun 371:159–162
Colie S, Van Veldhoven PP, Kedjouar B et al (2009) Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation. Cancer Res 69:9346–9353
Lee H, Deng J, Kujawski M et al (2010) STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med 16:1421–1428
Acknowledgement
Support to TL’s team by INSERM, Université Paul Sabatier, ANR (SphingoDR program), RITC, Ligue Nationale Contre le Cancer (Equipe Labellisée 2013), and VML is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Colacios, C., Sabourdy, F., Andrieu-Abadie, N., Ségui, B., Levade, T. (2015). Basics of Sphingolipid Metabolism and Signalling. In: Hannun, Y., Luberto, C., Mao, C., Obeid, L. (eds) Bioactive Sphingolipids in Cancer Biology and Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-20750-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-20750-6_1
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20749-0
Online ISBN: 978-3-319-20750-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)